Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials
Headache - United Kingdom
doi 10.1111/head.13508
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 3, 2019
Authors
Publisher
Wiley